Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination

Prevalence and type distribution of human papillomavirus in cervical adenocarcinoma in Korean women

(2013) Jong-Sup Park et al.   GYNECOLOGIC ONCOLOGY

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

(2012) Wiebren A. Tjalma et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16

(2012) Jacolien van der Marel et al.   INTERNATIONAL JOURNAL OF CANCER

A novel blueprint for ‘top down’ differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia

(2012) Michael Herfs et al.   JOURNAL OF PATHOLOGY

Unusual Endocervical Adenocarcinomas

(2011) Kay J. Park et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection

(2011) C. C. Roberts et al.   JOURNAL OF CLINICAL MICROBIOLOGY

One virus, one lesion-individual components of CIN lesions contain a specific HPV type

(2011) Wim Quint et al.   JOURNAL OF PATHOLOGY

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Cosette M Wheeler et al.   LANCET ONCOLOGY

Absence of High-Risk Human Papillomavirus (HPV) Detection in Endocervical Adenocarcinoma with Gastric Morphology and Phenotype

(2010) Yasuki Kusanagi et al.   AMERICAN JOURNAL OF PATHOLOGY

Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA

(2010) Gerald Coquillard et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluation of the performance of the novel PapilloCheck® HPV genotyping test by comparison with two other genotyping systems and the HC2 test

(2010) Betti Schopp et al.   JOURNAL OF MEDICAL VIROLOGY

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18

(2009) Wen Chen et al.   CANCER CAUSES & CONTROL

Adenocarcinoma: A unique cervical cancer

(2009) Lilian T. Gien et al.   GYNECOLOGIC ONCOLOGY

Screening and adenocarcinoma of the cervix

(2009) Peter Sasieni et al.   INTERNATIONAL JOURNAL OF CANCER

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

(2009) Darron R. Brown et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

(2009) Mark Schiffman et al.   Infectious Agents and Cancer